|
Boehringer Ingelheim presents positive efficacy data for tiotropium in asthma …
The Pharma Letter German family-owned drug major Boehringer Ingelheim presented a new subset of data from the Phase III UniTinA-asthma program relating to its already-marketed drug Spiriva (tiotropium) at the 2013 American Academy of Allergy, Asthma & Immunology … Boehringer Ingelheim drug shows benefits in new asthma trial |
View full post on asthma – Google News